Asset Analysis
09/06/26
Five key areas: energy, computing, and the infrastructure that supports AI
Operating Performance
03/06/26
Anatomy of an asymmetric position in Microsoft: calls on MSFU
Asset Analysis
12/05/26
Analysis and Opinion: Microsoft Corporation ($MSFT)
Asset Analysis
23/04/26
Analysis and Opinion: Aurinia Pharma ($AUPH)
Asset Analysis
20/04/26
Analysis and Opinion: Rocket Pharmaceuticals ($RCKT) — Gene Therapy, KRESLADI™, and the PDUFA Deadline of 2026
Operating Performance
06/04/26
Energy Positioning Amid a Shift in the Geopolitical Balance: An Analysis of a Call Option on Brent (+769%)
Market Strategies
10/03/26
Volatility Convexity Strategy and Strategic Construction of Nasdaq Exposure
Markets by Diego
15/02/26
Analysis and Opinion: Candel Therapeutics ($CADL) — Viral Immunotherapy, CAN-2409, and the BLA That Will Define 2026
Asset Analysis
09/02/26
Analysis and Opinion: Verisure Plc ($VSURE) — Recurring ARR, deleveraging, and the post-IPO correction
Asset Analysis
15/01/26
Analysis and Opinion: Izertis S.A. ($IZER) — Technology Consulting Firm, the Izertis 2030 Plan, and the Growth Thesis
Operating Performance
13/01/26
When the Market Defies Logic: A Look at the «Broken Equilibrium» and Asymmetric Hedging with Leveraged ETFs
Asset Analysis
06/01/26
Analysis and Opinion: Bolloré ($BOLL) and Cirsa Enterprises ($CIRSA) — Value Investing and Regulated Growth in Europe
RO
Operating Performance
01/12/25
Operations in Biopharmas: Results of One of My Strategies
Operating Performance
26/11/25
Reactivating Smart Hedging: A Strategy Using Leveraged ETFs
Markets by Diego
25/11/25
Analysis and Opinion: Zegona Communications Plc ($ZEG) — Vodafone Spain, Buy-Fix-Sell, and the Restructuring Thesis
Markets by Diego
19/11/25
Analysis and Opinion: TMC the metals company Inc. ($TMC) — Critical Metals, Underwater Mining, and the CCZ Thesis
Markets by Diego
16/11/25
Analysis and Opinion: Dyne Therapeutics Inc. ($DYN) — the FORCE™ platform, DMD/DM1, and the fast-track approval thesis
Markets by Diego
11/11/25
Analysis and Opinion: $IOVA, $GANX, and $GOSS — TIL therapies, allosteric molecules, and seralutinib in clinical trials
Markets by Diego
04/11/25
Short position in leveraged inverse ETF options in anticipation of a potential market correction
Markets by Diego
03/11/25
Analysis and Opinion: W&T Offshore ($WTI) and MercadoLibre ($MELI) — Value in Offshore E&P and Growth in the Latin American Digital Ecosystem
Uncategorized
27/10/25
Extreme Compression Week: Four Critical Nodes Converge in the Global Market
Market Strategies
15/10/25
Hedging with Options on Indexed and Leveraged ETFs against Short Futures Positioning Strategy
Market Report
12/10/25
The Broken Balance: How AI Euphoria and Leverage Have Pushed the Market to the Brink
Asset Analysis
10/10/25
Analysis and Opinion: Adaptimmune Therapeutics Plc ($ADAP)
Options Report
06/10/25
SPX Options Analysis: Positive Gamma Structure and Volatility in Contango - 06/10/2025
Market Report
01/10/25
Trump Faces His Third Government Shutdown: Potential Impact on Wall Street
Operating Performance
29/09/25
Option Performance for $CRNX
Asset Analysis
23/09/25
Analysis and Opinion: $ACHV, $ZVRA, and $CRNX — September 23, 2025
Options Report
22/09/25
SPX Options Analysis: Concentrated Gamma and Correction Risk to 08 DTE - 09/22/2025
Options Report
15/09/25
SPX Options Analysis: Controlled Range Ahead of Key Events — September 15, 2025
Market Report
07/09/25
Market Analysis by Diego García del Río - 07/09/2025